BACKGROUND: Acquired immunity to malaria develops with increasing age and repeated infections. Understanding immune correlates of protection from malaria would facilitate vaccine development and identification of biomarkers that reflect changes in susceptibility resulting from ongoing malaria control efforts. METHODS: The relationship between immunoglobulin G (IgG) antibody and both interferon γ (IFN-γ) and interleukin 10 (IL-10) responses to the 42-kD C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP142) and the risk of (re)infection were examined following drug-mediated clearance of parasitemia in 94 adults and 95 children in an area of holoendemicity of western Kenya. RESULTS: Positive IFN-γ enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunosorbent spot assay (ELISPOT) responses to MSP142 3D7 were associated with delayed time to (re)infection, whereas high-titer IgG antibodies to MSP142 3D7 or FVO alleles were not independently predictive of the risk of (re)infection. When IFN-γ and IL-10 responses were both present, the protective effect of IFN-γ was abrogated. A Cox proportional hazard model including IFN-γ, IL-10, MSP142 3D7 IgG antibody responses, hemoglobin S genotype, age, and infection status at baseline showed that the time to blood-stage infection correlated positively with IFN-γ responses and negatively with IL-10 responses, younger age, and asymptomatic parasitemia. CONCLUSIONS: Evaluating combined allele-specific cellular and humoral immunity elicited by malaria provides a more informative measure of protection relative to evaluation of either measure alone.
BACKGROUND: Acquired immunity to malaria develops with increasing age and repeated infections. Understanding immune correlates of protection from malaria would facilitate vaccine development and identification of biomarkers that reflect changes in susceptibility resulting from ongoing malaria control efforts. METHODS: The relationship between immunoglobulin G (IgG) antibody and both interferon γ (IFN-γ) and interleukin 10 (IL-10) responses to the 42-kD C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 (MSP142) and the risk of (re)infection were examined following drug-mediated clearance of parasitemia in 94 adults and 95 children in an area of holoendemicity of western Kenya. RESULTS: Positive IFN-γ enzyme-linked immunosorbent assay (ELISA) and enzyme-linked immunosorbent spot assay (ELISPOT) responses to MSP142 3D7 were associated with delayed time to (re)infection, whereas high-titer IgG antibodies to MSP142 3D7 or FVO alleles were not independently predictive of the risk of (re)infection. When IFN-γ and IL-10 responses were both present, the protective effect of IFN-γ was abrogated. A Cox proportional hazard model including IFN-γ, IL-10, MSP142 3D7 IgG antibody responses, hemoglobin S genotype, age, and infection status at baseline showed that the time to blood-stage infection correlated positively with IFN-γ responses and negatively with IL-10 responses, younger age, and asymptomatic parasitemia. CONCLUSIONS: Evaluating combined allele-specific cellular and humoral immunity elicited by malaria provides a more informative measure of protection relative to evaluation of either measure alone.
Entities:
Keywords:
Merozoite Surface Protein 1; cellular immunity; human immunity; humoral immunity; interferon-gamma; interleukin-10; longitudinal study; observational study; sickle cell trait
Authors: A Sabchareon; T Burnouf; D Ouattara; P Attanath; H Bouharoun-Tayoun; P Chantavanich; C Foucault; T Chongsuphajaisiddhi; P Druilhe Journal: Am J Trop Med Hyg Date: 1991-09 Impact factor: 2.345
Authors: Chandy C John; Rebecca A O'Donnell; Peter O Sumba; Ann M Moormann; Tania F de Koning-Ward; Christopher L King; James W Kazura; Brendan S Crabb Journal: J Immunol Date: 2004-07-01 Impact factor: 5.422
Authors: Arlene E Dent; Ann M Moormann; Christopher T Yohn; Rhonda J Kimmel; Peter O Sumba; John Vulule; Carole A Long; David L Narum; Brendan S Crabb; James W Kazura; Daniel J Tisch Journal: Malar J Date: 2012-08-21 Impact factor: 2.979
Authors: Jessica R Loughland; Gabriela Minigo; Julie Burel; Peta E Tipping; Kim A Piera; Fiona H Amante; Christian R Engwerda; Michael F Good; Denise L Doolan; Nicholas M Anstey; James S McCarthy; Tonia Woodberry Journal: Infect Immun Date: 2016-04-22 Impact factor: 3.441
Authors: Steven Kho; Jutta Marfurt; Rintis Noviyanti; Andreas Kusuma; Kim A Piera; Faustina H Burdam; Enny Kenangalem; Daniel A Lampah; Christian R Engwerda; Jeanne R Poespoprodjo; Ric N Price; Nicholas M Anstey; Gabriela Minigo; Tonia Woodberry Journal: Infect Immun Date: 2015-06-01 Impact factor: 3.441
Authors: Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport Journal: Am J Trop Med Hyg Date: 2013-09-09 Impact factor: 2.345
Authors: Peter Liehl; Patrícia Meireles; Inês S Albuquerque; Mykola Pinkevych; Fernanda Baptista; Maria M Mota; Miles P Davenport; Miguel Prudêncio Journal: Infect Immun Date: 2015-01-12 Impact factor: 3.441
Authors: Natalie M Bowman; Jonathan J Juliano; Cynthia J Snider; Oksana Kharabora; Steven R Meshnick; John Vulule; Chandy C John; Ann M Moormann Journal: Am J Trop Med Hyg Date: 2016-08-01 Impact factor: 2.345
Authors: Arlene E Dent; Rie Nakajima; Li Liang; Elisabeth Baum; Ann M Moormann; Peter Odada Sumba; John Vulule; Denise Babineau; Arlo Randall; D Huw Davies; Philip L Felgner; James W Kazura Journal: J Infect Dis Date: 2015-04-15 Impact factor: 5.226
Authors: Mykola Pinkevych; Janka Petravic; Kiprotich Chelimo; John Vulule; James W Kazura; Ann M Moormann; Miles P Davenport Journal: J Infect Dis Date: 2013-11-21 Impact factor: 5.226